Ferrņ, M T

Myasthenia gravis remission and anti-AChR ab reduction after immunosuppressive and anti-neoplastic therapy in a patient with thymic Hodgkin's disease. [electronic resource] - Journal of neurology Sep 2006 - 1241-2 p. digital

Publication Type: Case Reports; Letter

0340-5354

10.1007/s00415-006-0171-6 doi


Antineoplastic Agents--therapeutic use
Autoantibodies--metabolism
Female
Hodgkin Disease--therapy
Humans
Immunosuppressive Agents--therapeutic use
Middle Aged
Myasthenia Gravis--immunology
Receptors, Cholinergic--immunology
Thymectomy--methods